Business Wire

AB InBev PureDraught™ Keg System Wins World Beverage Innovation Award

18.11.2019 17:20:00 EET | Business Wire | Press release

Share

AB InBev and its Global Innovation and Technology Center (GITEC) announced that PureDraught™, a revolutionary one-way polymer keg system, won a World Beverage Innovation Award for “Best Manufacturing/Processing Innovation.” The honor was awarded at the BrauBeviale 2019 trade fair in Nuremberg, Germany.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191118005495/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

PureDraught™ keeps beer fresher up to four times longer than a traditional steel keg and reduces the carbon footprint of shipping beer -- all while offering more versatility and variety for bar and restaurant owners. (Photo: Business Wire)

PureDraught™ keeps beer fresher up to four times longer than a traditional steel keg and reduces the carbon footprint of shipping beer -- all while offering more versatility and variety for bar and restaurant owners.

Using a custom-molded, double-walled, bottle-in-bottle polymer keg, PureDraught allows air or gas to be fed into the outer bottle, which keeps its shape and pushes the beer out of the inner bottle. This innovation prevents any air or dispense gas from touching the beer, allowing the beer to remain fresh for 30 days after being tapped instead of just a week.

In addition, PureDraught comes in 6L, 12L and 18L sizes rather than the standard 30L or larger steel keg size, allowing for more flexibility and less wasted product by bar and restaurant owners. The kegs can be stored and dispensed from upright or on their side on a shelf, making them more versatile.

“We are honored that our research and technological innovation for PureDraught has been recognized by the prestigious World Beverage Innovation Awards,” said Rodrigo Sozo, Vice President of AB InBev GITEC. “This is a validation of the hard work and passion of our team as they set out to develop a transformational innovation for draught beer, including superior quality, less carbon footprint and more variety of beers on tap. We are also excited about how the technology platform creates new consumer experiences for all types of occasions of draught beer consumption.”

There are no additional costs for a bar to use the PureDraught system or the beer in the one-way kegs, and in most markets, the system’s custom keg coupler is provided and connected to a bar’s existing beer and gas lines by AB InBev free of charge.

Currently, PureDraught is in use with AB InBev brands in more than eight countries, including the U.S., Mexico, Brazil, China, Italy, Japan and South Korea as well as additional areas of Europe and Africa, providing the best pour of brands like Stella Artois. For more information, including how to convert your establishment to PureDraught, visit https://puredraught.com/.

About AB InBev GITEC

The Global Innovation and Technology Center (GITEC) at AB InBev is the hub of innovation for the company, working across teams and the company’s more than 500 brands to develop new products, processes and technologies. Driven by a team of more than 120 passionate R&D talents from more than 20 countries, GITEC works to revolutionize packaging, make the brewing process more efficient and sustainable, create breakthroughs in how our beers are delivered and dispensed, and to offer new tasting and consumer experiences.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact:
Shawn Malayter
Greenhouse Partners
872-267-2636
smalayter@greenhousepartners.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f

Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye